Home
Science
Mocravimod
Acute Myeloid Leukemia & Hematopoietic Cell Transplantation
CAR T Cells
Our Pipeline
Publications
MO-TRANS
Press
About
Our Leadership Team
Advisory Board
Investors
Our Partners
ESG and Recognition
Contact
Select Page
mocravimod
by
admin
|
Jun 16, 2022
Search for:
Recent Posts
PRIOTHERA révolutionne le standard des soins dans les thérapies cellulaires en hémato-oncologie
Cancer : Priothera veut limiter les risques des greffes de cellules souches
Priothera to Present Trial in Progress Poster for Mocravimod at 2024 American Society of Hematology (ASH) Annual Meeting
LMA : Phase III et levée de fonds en cours pour Priothera
Booster l’efficacité des thérapies cellulaires
Recent Comments
Priothera to start Phase IIb/III trial of acute myeloid leukaemia therapy
on
Priothera Receives FDA clearance of Investigational New Drug (IND)
FDA grants orphan drug designation to mocravimod for acute myeloid leukemia - Healio - The Online Chemists
on
Priothera – FDA and EMA Grant Orphan Drug Designation to mocravimod for the treatment of Acute Myeloid Leukemia (AML) in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT)
Recent Comments